NAVIDEA BIOPHARMACEUTICALS, INC. Earnings Per Share (Diluted)
NAVIDEA BIOPHARMACEUTICALS, INC. reported Earnings Per Share (Diluted) of -$0.09 per share for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2019-03-15
- NAVIDEA BIOPHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2018-09-30 was -$0.02.
- NAVIDEA BIOPHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2018-06-30 was -$0.02.
- NAVIDEA BIOPHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2018-03-31 was -$0.04, a 107.69% decline year-over-year.
- NAVIDEA BIOPHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2017-12-31 was -$0.03.
- NAVIDEA BIOPHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2018 was -$0.09, a 120.00% decline from fiscal 2017.
- NAVIDEA BIOPHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2017 was $0.45.
- NAVIDEA BIOPHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2016 was -$0.09.
- NAVIDEA BIOPHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2015 was -$0.18.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$0.09 10-K · filed 2019-03-15 | |||
| 2018-09-30 | -$0.02 10-Q · filed 2018-11-09 | -$0.08 10-Q · filed 2018-11-09 | ||
| 2018-06-30 | -$0.02 10-Q · filed 2018-08-08 | -$0.06 10-Q · filed 2018-08-08 | ||
| 2018-03-31 | -$0.04 10-Q · filed 2018-05-09 | |||
| 2017-12-31 | -$0.03 10-K · filed 2018-03-15 | $0.45 10-K · filed 2019-03-15 | ||
| 2017-09-30 | -$0.01 10-Q · filed 2018-11-09 | -$0.04 derived: net income ÷ weighted average shares · filed 2018-11-09 | $0.47 10-Q · filed 2018-11-09 | $0.47 derived: net income ÷ weighted average shares · filed 2018-11-09 |
| 2017-06-30 | -$0.03 10-Q · filed 2018-08-08 | $0.49 10-Q · filed 2018-08-08 | $0.48 derived: net income ÷ weighted average shares · filed 2018-08-08 | $0.48 derived: net income ÷ weighted average shares · filed 2018-08-08 |
| 2017-03-31 | $0.52 10-Q · filed 2018-05-09 | $0.51 derived: net income ÷ weighted average shares · filed 2018-05-09 | $0.51 derived: net income ÷ weighted average shares · filed 2018-05-09 | $0.47 derived: net income ÷ weighted average shares · filed 2018-05-09 |
| 2016-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$0.03 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$0.07 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$0.09 10-K · filed 2018-03-15 |
| 2016-09-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-11-09 | -$0.04 derived: net income ÷ weighted average shares · filed 2017-11-09 | -$0.07 10-Q · filed 2017-11-09 | |
| 2016-06-30 | -$0.04 10-Q · filed 2017-08-09 | -$0.07 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$0.02 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | -$0.18 10-K · filed 2018-03-15 |